doi: 10.1016/0002-9394(88)90008-6.
Recombinant tissue plasminogen activator to lyse experimentally induced retinal arterial thrombi
Affiliations
- PMID: 3125746
- DOI: 10.1016/0002-9394(88)90008-6
Item in Clipboard
Recombinant tissue plasminogen activator to lyse experimentally induced retinal arterial thrombi
Am J Ophthalmol.
.
Abstract
We evaluated the efficacy of intravenously administered recombinant tissue plasminogen activator to lyse laser-induced arterial thrombi in the stroke-prone, spontaneously hypertensive rat model. The arterial thrombi were confirmed histologically, and assessed by color photographs and fluorescein angiography before and after intravenous tissue plasminogen activator or saline therapy. Experimental animals received tissue plasminogen activator (1 mg/kg of body weight) given intravenously over one hour, and control animals received similar volumes of normal saline. Tissue plasminogen activator was effective in lysing experimental retinal arterial thrombi.
Similar articles
-
Tissue plasminogen activator in the treatment of experimental retinal vein occlusion.Retina. 1989;9(1):1-7. doi: 10.1097/00006982-198909010-00001. Retina. 1989. PMID: 2497501
-
Permeable Thrombi Are Associated With Higher Intravenous Recombinant Tissue-Type Plasminogen Activator Treatment Success in Patients With Acute Ischemic Stroke.Stroke. 2016 Aug;47(8):2058-65. doi: 10.1161/STROKEAHA.116.013306. Epub 2016 Jun 23. Stroke. 2016. PMID: 27338928
-
[Major functional recuperation of branch retinal artery occlusion from thromboses in situ].Can J Ophthalmol. 2008 Oct;43(5):608-9. doi: 10.1139/i08-136. Can J Ophthalmol. 2008. PMID: 18982050 French. No abstract available.
-
[Thrombolytic agents].Nihon Rinsho. 2014 Jul;72(7):1254-7. Nihon Rinsho. 2014. PMID: 25163317 Review. Japanese.
-
Thrombolytic therapy.Ann N Y Acad Sci. 1991;614:259-69. doi: 10.1111/j.1749-6632.1991.tb43708.x. Ann N Y Acad Sci. 1991. PMID: 1902640 Review. No abstract available.
Cited by
-
Intravitreal recombinant tissue plasminogen activator in the treatment of experimentally induced bacterial endophthalmitis.Int Ophthalmol. 1991 Mar;15(2):79-86. doi: 10.1007/BF01046426. Int Ophthalmol. 1991. PMID: 1902438
-
Large-Scale Protein Analysis of Experimental Retinal Artery Occlusion.Int J Mol Sci. 2023 Apr 27;24(9):7919. doi: 10.3390/ijms24097919. Int J Mol Sci. 2023. PMID: 37175625 Free PMC article.
-
The use of tissue plasminogen activator in postvitrectomy cases.Int Ophthalmol. 1993 Apr;17(2):95-100. doi: 10.1007/BF00942782. Int Ophthalmol. 1993. PMID: 8407122
-
Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent.Drugs. 1989 Sep;38(3):346-88. doi: 10.2165/00003495-198938030-00003. Drugs. 1989. PMID: 2509190 Review.
-
Intra-retinal Arterial Cannulation using a Microneedle for Central Retinal Artery Occlusion.Sci Rep. 2018 Jan 22;8(1):1360. doi: 10.1038/s41598-018-19747-7. Sci Rep. 2018. PMID: 29358594 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
